|
28 Mar 2025 |
Tarsons Products
|
Consensus Share Price Target
|
301.85 |
597.40 |
- |
97.91 |
buy
|
|
|
|
|
16 Aug 2024
|
Tarsons Products
|
ICICI Securities Limited
|
301.85
|
408.00
|
423.15
(-28.67%)
|
Target met |
Sell
|
|
|
Tarson’s Q1FY25 standalone biz revenue and margins were impacted due to a slowdown in its domestic business (down ~4% YoY).
|
|
12 Sep 2023
|
Tarsons Products
|
ICICI Securities Limited
|
301.85
|
590.00
|
527.55
(-42.78%)
|
|
Accumulate
|
|
|
Tarsons Products (Tarsons) offers a range of plastic labware products. Over the years, it has gained ~25% market share (Source: Company) in a segment which was historically dominated by MNCs. Its network consists of over 150 distributors and more than 500 sub-distributors which provide pan-India visibility to its products.
|
|
14 Aug 2023
|
Tarsons Products
|
Edelweiss
|
301.85
|
688.00
|
559.30
(-46.03%)
|
|
Buy
|
|
|
Macro headwinds prevail
|
|
15 Feb 2023
|
Tarsons Products
|
Edelweiss
|
301.85
|
795.00
|
615.50
(-50.96%)
|
|
Buy
|
|
|
Soft performance continues amid weak demand
|
|
09 Dec 2022
|
Tarsons Products
|
Hem Securities
|
301.85
|
1157.00
|
732.05
(-58.77%)
|
|
Buy
|
|
|
|
|
08 Nov 2022
|
Tarsons Products
|
ICICI Securities Limited
|
301.85
|
755.00
|
717.20
(-57.91%)
|
|
Hold
|
|
|
Tarsons Products’ (Tarsons) Q2FY23 performance was marginally below our expectations. Revenue declined 6.3% YoY (+3.8% QoQ) to Rs712mn on a high covid-led base (I-Sec: Rs741mn).
|
|
10 Aug 2022
|
Tarsons Products
|
ICICI Securities Limited
|
301.85
|
756.00
|
772.05
(-60.90%)
|
Target met |
Hold
|
|
|
Tarsons Products’ (Tarsons) Q1FY23 performance was below our expectations on
all fronts. Revenues were flat YoY (-19.2%QoQ) at Rs686mn on a high covid-led base (I-Sec: Rs753mn).
|
|
08 Aug 2022
|
Tarsons Products
|
Edelweiss
|
301.85
|
949.00
|
772.05
(-60.90%)
|
|
Buy
|
|
|
Focus is to maintain margins
|
|
13 Jul 2022
|
Tarsons Products
|
Edelweiss
|
301.85
|
949.00
|
847.10
(-64.37%)
|
|
Buy
|
|
|
Focus on maintaining margins
|
|
17 Jun 2022
|
Tarsons Products
|
Edelweiss
|
301.85
|
949.00
|
682.25
(-55.76%)
|
|
Buy
|
|
|
Poised for strong growth supported by inimitable business model
|
|
15 Nov 2021
|
Tarsons Products
|
Ventura
|
301.85
|
|
|
|
IPO Note
|
|
|
|
|
15 Nov 2021
|
Tarsons Products
|
Hem Securities
|
301.85
|
|
|
|
IPO Note
|
|
|
Tarsons Products Ltd is an Indian labware company engaged in the designing, development, manufacturing and marketing of consumables', reusables' and others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies,...
|
|
13 Nov 2021
|
Tarsons Products
|
HDFC Securities
|
301.85
|
|
|
|
IPO Note
|
|
|
Issue Open: Nov 15 Nov 17 2021 Price Band: Rs. 635 662 (Discount of Rs 61 for all eligible employees) *Issue Size: Rs 1023.8 cr (Fresh issue of Rs 150 cr+ offer for sale of 13,200,000 eq sh) Reservation for: QIB Upto 50% eq sh Non Institutional atleast 15% eq sh Retail Upto 35% eq sh Employee Upto 60,000 eq sh Tarsons Products Limited - IPO Note
|
|
12 Nov 2021
|
Tarsons Products
|
Ashika Research
|
301.85
|
|
|
|
IPO Note
|
|
|
22 Equity Shares and in multiples thereof. Public issue of 15,465,861 Equity shares of Face value Rs. 2 each, (Comprising of fresh issue of 2,265,861 Equity Shares* (Rs. 150 cr.) and Offer for Sale of...
|
|
12 Nov 2021
|
Tarsons Products
|
Angel Broking
|
301.85
|
|
|
|
IPO Subscribe
|
|
|
Tarsons Products Ltd is a leading Indian manufacturing company by revenue in India in laboratory consumable and life sciences industry with ~9-12% market share in the labware market in 2020 (Frost & Sullivan Report). Tarsons' product portfolio is classified into three key categories, which include Consumables, Reusables, and Others. The company generated ~23% of its
|